Gao et al. described a statistically significant association of rs11672691 with clinical features of aggressive PC, such as high tumor stage, high prostate-specific antigen (PSA) levels in 2738 men with disease progression, and the development of castration-resistant PC (CRPC) [47]. This evidence concerns the gene KLK3 and neoplasm.